Oppenheimer Asset Management Inc. lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 33.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,132 shares of the company's stock after purchasing an additional 12,180 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in Option Care Health were worth $1,717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also made changes to their positions in the company. Whalen Wealth Management Inc. boosted its position in Option Care Health by 12.2% during the first quarter. Whalen Wealth Management Inc. now owns 12,213 shares of the company's stock valued at $427,000 after purchasing an additional 1,326 shares during the last quarter. Praxis Investment Management Inc. purchased a new stake in shares of Option Care Health during the 1st quarter worth about $205,000. Blue Trust Inc. lifted its holdings in shares of Option Care Health by 95.4% during the 1st quarter. Blue Trust Inc. now owns 5,282 shares of the company's stock valued at $185,000 after buying an additional 2,579 shares during the last quarter. Janney Capital Management LLC acquired a new stake in shares of Option Care Health during the 1st quarter valued at about $369,000. Finally, Johnson Investment Counsel Inc. grew its stake in shares of Option Care Health by 3.7% in the 1st quarter. Johnson Investment Counsel Inc. now owns 87,691 shares of the company's stock valued at $3,065,000 after buying an additional 3,120 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. Finally, Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $35.50.
Get Our Latest Stock Report on Option Care Health
Option Care Health Stock Performance
OPCH traded down $0.53 during trading on Tuesday, hitting $31.95. The stock had a trading volume of 1,402,098 shares, compared to its average volume of 1,864,716. The firm has a market cap of $5.23 billion, a PE ratio of 25.77, a P/E/G ratio of 1.96 and a beta of 0.73. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a 50 day simple moving average of $32.09 and a 200-day simple moving average of $31.00.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the company posted $0.26 earnings per share. The firm's revenue for the quarter was up 16.3% on a year-over-year basis. Analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.